Editor’s note: Welcome to 2021, and to our first in a year-long series of posts that will explore the essentials in antibody discovery. We’re starting off with a frequently under-appreciated...
Examining mutations in the SARS-CoV-2 Spike (S) Protein Receptor Binding Domain (RBD) at the ACE2 receptor S protein interface
We’ve reported on the SARS-CoV-2 S protein mutant D614G in past blog...
Antibody Solutions is doing its part to respond to the COVID-19 pandemic, including original research, tool discovery, and participation in in-house and client-sponsored discovery programs. In this...
Accessing the Untapped Potential of 33% of Human IgG
Harvard economist Michael Porter, PhD offers a clever observation that’s as seemingly apropos to science as it is business: "The essence of...
In the science shot heard ‘round the world, Pfizer and BioNTech announced Monday that their vaccine candidate (aka “BNT162b2”) appears to be more than 90% effective in preventing SARS-CoV-2 among...
Antibody Solutions helps biopharmaceutical companies advance their discovery of better diagnostics & therapeutics by delivering fit-for-purpose antibodies. With an acute customer-service focus, we provide comprehensive project management & technical support in a fee-for-service, pay-as-you-go model.
biopharma companies served and counting
of clients return with new assignments
years of helping our clients succeed
of the top 10 pharmas worldwide trust us
When we first meet with a client, we often start right here: What's standing in the way of your success?
And no matter their answer, we stand at the ready to help—with deep antibody discovery expertise, diverse technology platforms and an overall customer experience model that makes every new success seem more natural than the last.
Let’s get the conversation started for your next custom antibody discovery project.